184.71
price up icon0.49%   0.90
 
loading

Beigene Ltd Adr Stock (BGNE) Forecast

The Beigene Ltd Adr (BGNE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $185.75, representing a +0.56% increase from the current price of $184.71. The highest analyst price target is $197.57, and the lowest is $173.92.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BGNE Price Target
Average 244.65 (+32.45% Upside)
loading

Is Beigene Ltd Adr (BGNE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 46.17 Neutral
STOCH(9,6) 76.46 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -4.637 Buy
ADX(14) 23.72 Neutral
William %R -17.60 Sell
CCI(14) 31.84 Neutral
Buy: 1 Sell: 2 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
180.06
Buy
182.67
Buy
MA20
186.42
Sell
185.68
Sell
MA50
196.69
Sell
193.16
Sell
MA100
201.94
Sell
193.08
Sell
MA200
178.71
Buy
187.06
Sell
Buy: 3 Sell: 7 Neutral: 0
Summary: Sell
According to our latest analysis, BGNE could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BGNE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 46.17 indicates that BGNE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 76.46 indicates that BGNE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BGNE is oversold. This suggests that BGNE price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 23.72 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 31.84 indicates that BGNE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term BGNE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Beigene Ltd Adr financial reports and earnings history, Beigene Ltd Adr (BGNE) stock could reach $185.20 by 2030, $350.73 by 2040 and $346.80 by 2050. See the projected annual prices until 2050 of the Beigene Ltd Adr stock below:

  • Beigene Ltd Adr (BGNE) is expected to reach an average price of $237.84 in 2035, with a high prediction of $258.50 and a low estimate of $231.82. This indicates an $28.77% rise from the last recorded price of $184.71.
  • Beigene Ltd Adr (BGNE) stock is projected to chart a bullish course in 2040, with an average price target of $333.28, representing an $80.43% surge from its current level. The forecast ranges from a conservative $288.51 to a sky-high $350.73.
  • Our analysts predict Beigene Ltd Adr (BGNE) to jump 28.59% by 2045, soaring from $234.03 to an average price of $237.52, potentially reaching $276.32. While $234.03 is the low estimate, the potential upside is significant.
  • Beigene Ltd Adr (BGNE) stock is expected to climb by 2050, reaching an average of $319.06, a $72.74% jump from its current level. However, a wide range of estimates exists, with high and low targets of $346.80 and $262.18, respectively, highlighting the market's uncertainty.

Beigene Ltd Adr Stock (BGNE) Year by Year Forecast

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2025

Beigene Ltd Adr Stock (BGNE) is expected to reach an average price of $244.65 in 2025, with a high prediction of $347.10 and a low estimate of $142.21. This indicates an +32.45% rise from the last recorded price of $184.71.
Month Average Low High Change from today's price
March, 2025 $177.98 $173.92 $197.57 -3.64%
April, 2025 $147.01 $142.21 $187.68 -20.41%
May, 2025 $184.98 $145.94 $189.36 +0.14%
June, 2025 $190.04 $160.25 $190.35 +2.89%
July, 2025 $206.41 $178.99 $206.75 +11.75%
August, 2025 $219.93 $202.88 $228.90 +19.07%
September, 2025 $244.45 $228.11 $279.94 +32.34%
October, 2025 $264.19 $231.93 $278.59 +43.03%
November, 2025 $310.51 $250.16 $311.81 +68.11%
December, 2025 $320.66 $305.56 $347.10 +73.60%

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2026

The predicted value for Beigene Ltd Adr (BGNE) in 2026 is set at an average of $347.41. Estimates vary from a peak of $451.38 to a trough of $243.44, indicating an +88.08% surge from the present price of $184.71.
Month Average Low High Change from today's price
January, 2026 $310.09 $277.70 $341.98 +67.88%
February, 2026 $281.53 $243.44 $310.25 +52.42%
March, 2026 $369.30 $268.37 $370.28 +99.94%
April, 2026 $375.41 $337.58 $413.34 +103.24%
May, 2026 $373.37 $307.84 $380.22 +102.14%
June, 2026 $332.75 $327.45 $385.44 +80.15%
July, 2026 $344.16 $313.80 $384.38 +86.32%
August, 2026 $371.51 $342.81 $393.04 +101.13%
September, 2026 $353.92 $332.97 $392.45 +91.61%
October, 2026 $346.98 $274.90 $373.72 +87.85%
November, 2026 $333.07 $263.63 $352.60 +80.32%
December, 2026 $387.62 $333.59 $451.38 +109.85%

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Beigene Ltd Adr (BGNE) is $280.40, with a high forecast of $417.25 and a low forecast of $143.55. This indicates an +51.80% increase from the last price of $184.71.
Month Average Low High Change from today's price
January, 2027 $404.35 $359.80 $405.58 +118.91%
February, 2027 $389.49 $367.20 $417.25 +110.87%
March, 2027 $298.73 $247.23 $393.49 +61.73%
April, 2027 $263.71 $245.10 $311.03 +42.77%
May, 2027 $248.88 $219.60 $282.43 +34.74%
June, 2027 $201.56 $197.70 $257.55 +9.12%
July, 2027 $213.85 $161.31 $238.11 +15.77%
August, 2027 $189.08 $187.04 $241.65 +2.37%
September, 2027 $159.33 $143.55 $204.10 -13.74%
October, 2027 $157.56 $152.93 $194.87 -14.70%
November, 2027 $214.21 $165.31 $221.87 +15.97%
December, 2027 $219.51 $185.95 $232.81 +18.84%

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2028

In 2028, Beigene Ltd Adr (BGNE) is projected to reach an average price of $228.32, with a high projection of $306.51 and a low estimate of $150.14. This indicates an +23.61% rise from the last price of $184.71.
Month Average Low High Change from today's price
January, 2028 $192.48 $189.57 $224.13 +4.20%
February, 2028 $160.47 $157.08 $199.47 -13.12%
March, 2028 $194.61 $150.14 $205.68 +5.36%
April, 2028 $200.74 $193.91 $236.27 +8.68%
May, 2028 $251.91 $202.11 $258.45 +36.38%
June, 2028 $292.31 $241.81 $306.51 +58.25%
July, 2028 $270.43 $267.44 $299.54 +46.41%
August, 2028 $242.25 $234.84 $276.66 +31.15%
September, 2028 $264.52 $236.38 $268.51 +43.21%
October, 2028 $275.91 $259.98 $298.57 +49.37%
November, 2028 $253.55 $239.99 $282.58 +37.27%
December, 2028 $204.54 $200.98 $255.77 +10.74%

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2029

The 2029 price forecast for Beigene Ltd Adr Stock (BGNE) is $202.69 on average, with a high prediction of $251.53 and a low estimate of $153.86. This represents an +9.73% increase from the previous price of $184.71.
Month Average Low High Change from today's price
January, 2029 $240.53 $204.45 $251.53 +30.22%
February, 2029 $224.77 $210.21 $242.75 +21.69%
March, 2029 $226.74 $217.68 $246.02 +22.75%
April, 2029 $205.26 $193.76 $237.83 +11.13%
May, 2029 $225.65 $183.04 $230.13 +22.16%
June, 2029 $214.08 $207.52 $231.95 +15.90%
July, 2029 $207.01 $197.85 $215.36 +12.07%
August, 2029 $174.94 $174.59 $211.19 -5.29%
September, 2029 $181.87 $159.68 $185.24 -1.54%
October, 2029 $178.85 $178.68 $211.62 -3.17%
November, 2029 $156.41 $153.86 $186.20 -15.32%
December, 2029 $179.52 $156.86 $184.82 -2.81%

Beigene Ltd Adr Stock (BGNE) Price Forecast for 2030

Beigene Ltd Adr Stock (BGNE) is expected to reach an average price of $208.20 in 2030, with a high forecast of $257.18 and a low forecast of $159.22. This signifies an +12.72% surge from the last price of $184.71.
Month Average Low High Change from today's price
January, 2030 $163.81 $161.72 $185.20 -11.31%
February, 2030 $168.82 $159.22 $177.88 -8.60%
March, 2030 $184.31 $164.74 $185.32 -0.22%
April, 2030 $189.39 $174.00 $196.40 +2.53%
May, 2030 $169.09 $165.25 $195.11 -8.46%
June, 2030 $185.73 $161.14 $187.37 +0.55%
July, 2030 $254.31 $182.74 $255.78 +37.68%
August, 2030 $219.93 $204.15 $257.18 +19.07%
September, 2030 $210.59 $205.35 $220.64 +14.01%
October, 2030 $218.14 $197.49 $220.86 +18.10%
November, 2030 $190.29 $183.72 $221.16 +3.02%
December, 2030 $185.88 $165.87 $203.15 +0.63%
$357.50
price down icon 0.20%
$33.69
price down icon 0.33%
$22.96
price up icon 2.04%
$74.40
price up icon 0.53%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):